I am not so much concerned about them not generating pure profits. They are in an expansion mode right now. They are trying to build a big cutomer base. It is not unusual for a buisness not to gerate profits while it is in a expansion mode. Meanwhile they need to spend money on people to retain them. Their people (employees) are their biggest assets. Why not spend money and shares on them. You want to retain good people. To do so RXMD needs to spend money and shares. Many buisnesses have a share option program that comes with a one year of a vesting term. It is a matter of business choice you make as a CEO. Are you satisfied with a mon and pop shop or are eager to build a congramallot. As a long investor I am not concerned about everyday fluctuation of the price. That is a thing that day tradors and shorters need to worry about. As long as RXMD is expanding the prescription count and the revenue number, I am not worried right now it. That is exactly what they should be doing im my opinion. As as long as they increase their revenue, I can take some increase in the share count as long as it is controled. Their profits should natually (organically) increase.
Market Data 
Markets 
AI
